Today: 20 May 2026
Natural gas tops $4 again: UNG jumps, U.S. gas stocks rise on cold forecasts and storage drawNEW YORK, December 30, 2025, 10:00 ET — Regular session
30 December 2025
2 mins read

Natural gas tops $4 again: UNG jumps, U.S. gas stocks rise on cold forecasts and storage drawNEW YORK, December 30, 2025, 10:00 ET — Regular session

  • U.S. February Henry Hub natural gas futures traded around $4.10 per mmBtu, up about 3%.
  • The United States Natural Gas Fund (UNG) rose about 3.8% in early trade, while major producers EQT and Antero Resources also gained.
  • Traders are watching early-January weather signals and the next U.S. storage report due December 31.

U.S. natural gas prices firmed on Tuesday, lifting the United States Natural Gas Fund (UNG) and shares of major gas-linked names as the winter demand picture tightened.

The move matters now because storage withdrawals are accelerating into year-end just as forecasters flag colder risks for parts of the U.S. Northeast. In winter, small shifts in temperature can quickly swing heating demand and prices.

It also comes with liquefied natural gas (LNG) export demand running near record levels, keeping a steady pull on U.S. supply even when domestic consumption eases. LNG “feedgas” is the pipeline gas delivered to export plants for liquefaction. Hellenic Shipping News

February Henry Hub natural gas futures traded at about $4.099 per million British thermal units (mmBtu), up 11.3 cents, according to Barchart data.

UNG, which is designed to track day-to-day moves in near-month NYMEX natural gas futures, rose 3.8% to about $13.54. EQT gained about 0.8% and Antero Resources rose about 2.1%, while LNG exporter Cheniere Energy and pipeline operator Kinder Morgan were also higher.

A key catalyst was the U.S. Energy Information Administration’s weekly storage report, released Monday due to holiday scheduling. Working gas in storage fell by 166 billion cubic feet (Bcf) in the week ended Dec. 19 to 3,413 Bcf, leaving inventories 24 Bcf below the five-year average, the EIA said.

Weather remains the next major driver. NOAA’s Climate Prediction Center said its 6–10 day outlook favored near- to below-normal temperatures for much of the Northeast U.S., a region where cold snaps tend to lift heating demand quickly.

Private forecasters have also pointed to a colder early-January window. Atmospheric G2 said colder-than-normal temperatures were expected across the U.S. Northeast for Jan. 3–7, according to Barchart’s market commentary.

Export demand has been the other leg of support. Average flows to the eight large U.S. LNG export plants rose to 18.5 billion cubic feet per day (bcfd) so far this month, up from the prior monthly record of 18.2 bcfd in November, Reuters reported, citing LSEG data.

LSEG also pegged average Lower 48 output at a record 110.1 bcfd in December, a supply-side offset that has kept traders sensitive to whether cold weather disrupts production or simply boosts demand.

“Forecasts are turning back colder a little bit and with this wicked winter weather, people are starting to buy,” Phil Flynn, senior analyst at Price Futures Group, said in the Reuters report. Hellenic Shipping News

For the next move, traders are focused on the next EIA storage report scheduled for Wednesday, Dec. 31 at 12:00 p.m. ET, and on whether updated weather models extend the Northeast cold risk deeper into January.

Technicals are also in view after the market reclaimed the $4 handle. Barchart’s key levels put first resistance near $4.081 and first support around $3.839 for the February contract, levels that can attract short-term trading interest when prices are choppy.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
NIO stock today: Premarket ticks higher as CATL battery shift report meets 2026 demand warning
Previous Story

NIO stock today: Premarket ticks higher as CATL battery shift report meets 2026 demand warning

Linde stock edges higher in thin year-end trade as investors eye Fed minutes
Next Story

Linde stock edges higher in thin year-end trade as investors eye Fed minutes

Go toTop